NASDAQ$BTTC

Black Titan Corp · Q3 2015 earnings

Q3 2015 earnings · · Investor relations

Headline financials

EPS (adj)

-$11.41

Previous: $0.30-3900.0%
Capital Expenditures

$47K

Previous: $8K+487.5%
Net Income

-$1.81M

Previous: $716K-352.4%
Operating Income

-$1.8M

Previous: -$738K-144.2%
Cash & Equivalents

$9.69M

Previous: $7.45M+30.1%
Total Assets

$14.9M

Previous: $13.2M+12.8%
Stock-Based Comp

$92K

Previous: $71K+29.6%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$0

Q2 2025
Beat estimate in 6 of 7 quarters(86%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro